| Name | Title | Contact Details |
|---|
Cosmo Bio USA is a company that provides quality life science products from leading Japanese manufacturers to laboratories, research institutes, life science education and testing organizations throughout North America.
Gate Pharmaceuticals is a North Wales, PA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
FFF Enterprises Inc is a Temecula, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Trevi Therapeutics, Inc. is a late-stage clinical development company developing Nalbuphine® ER for chronic pruritus (itch). Pruritus develops in various dermatologic, metabolic, hematologic, and neuropathic conditions. The Company is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis. Uremic pruritus is a persistent and debilitating itch in patients on dialysis that has been associated with significant impairment in quality of life and increased mortality. Prurigo nodularis is an intensely pruritic dermatologic condition characterized by unsightly and itchy skin papules and nodules. There are no approved therapies in the United States or Europe for either condition.
CanCap Pharmaceutical Ltd is a Richmond, BC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.